Jacobs Levy Equity Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95,498
Closed -$917K 986
2025
Q4
$917K Sell
95,498
-428,790
-82% -$4.05M ﹤0.01% 696
2025
Q3
$4.97M Buy
524,288
+387,440
+283% +$3.26M 0.02% 426
2025
Q2
$1.02M Buy
136,848
+23,613
+21% +$147K ﹤0.01% 754
2025
Q1
$688K Buy
113,235
+39,698
+54% +$275K ﹤0.01% 878
2024
Q4
$572K Buy
+73,537
New +$548K ﹤0.01% 796

Other funds holding CYRX

Jacobs Levy Equity Management's CYRX Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of CryoPort (CYRX) in Q1 2026, closing a stake of 95,498 shares — an estimated $917K sold.

Jacobs Levy Equity Management first reported a position in CYRX in Q4 2024 and held it in 5 quarters. The position peaked at $4.97M in Q3 2025. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining CryoPort position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 95,498 CryoPort shares in Q1 2026, an estimated $917K.
  • Jacobs Levy Equity Management first reported a position in CryoPort in Q4 2024 and held it in 5 quarters.
  • Jacobs Levy Equity Management's CryoPort position peaked at $4.97M in Q3 2025.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.